Nanobiotix (NBTX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $22.23, +4.46% vs the prior close of $21.28.
- Volume 116.40K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NBTX jumps 4.5% to $22.23. Closed at $22.23, +4.46% vs the prior close of $21.28. Day range $21.55–$22.92, opened at $21.89.
NBTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NBTX jumps 4.5% to $22.23
- Closed at $22.23, +4.46% vs the prior close of $21.28. Day range $21.55–$22.92, opened at $21.89.
- Volume was 116.40K shares, 0.7x its 50-day average of 156.76K.
- Price is -36.5% vs its 50-day average ($34.99) and -33.5% vs its 200-day average ($33.43).
- 52-week range $14.78–$57.14; today's close sits at 18% of that range, 61.1% below the 52-week high.
Oct 14, 2026 — NBTX dips 1.0% to $21.28, a 6-month low, 3 down days in a row
- Closed at $21.28, -0.98% vs the prior close of $21.49. Day range $21.15–$21.92, opened at $21.41.
- Volume was 80.60K shares, 0.5x its 50-day average of 156.98K — lighter than usual.
- Price is -39.8% vs its 50-day average ($35.33) and -36.3% vs its 200-day average ($33.43).
- 52-week range $14.78–$57.14; today's close sits at 15% of that range, 62.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — NBTX slides 8.2% to $21.49, a 6-month low
- Closed at $21.49, -8.16% vs the prior close of $23.40. Day range $21.22–$23.11, opened at $23.11.
- Volume was 231.30K shares, 1.5x its 50-day average of 155.39K.
- Price is -39.8% vs its 50-day average ($35.70) and -35.7% vs its 200-day average ($33.44).
- 52-week range $14.78–$57.14; today's close sits at 16% of that range, 62.4% below the 52-week high.
Oct 12, 2026 — NBTX dips 1.2% to $23.40
- Closed at $23.40, -1.18% vs the prior close of $23.68. Day range $22.80–$23.81, opened at $23.72.
- Volume was 173.30K shares, 1.1x its 50-day average of 154.52K.
- Price is -35.1% vs its 50-day average ($36.05) and -30.0% vs its 200-day average ($33.45).
- 52-week range $14.78–$57.14; today's close sits at 20% of that range, 59.0% below the 52-week high.
Oct 9, 2026 — NBTX jumps 3.4% to $23.68
- Closed at $23.68, +3.41% vs the prior close of $22.90. Day range $23.33–$24.50, opened at $23.51.
- Volume was 93.50K shares, 0.6x its 50-day average of 155.69K.
- Price is -34.9% vs its 50-day average ($36.35) and -29.2% vs its 200-day average ($33.45).
- 52-week range $14.78–$57.14; today's close sits at 21% of that range, 58.6% below the 52-week high.
Oct 8, 2026 — NBTX slides 7.0% to $22.90, a 6-month low
- Closed at $22.90, -6.99% vs the prior close of $24.62. Day range $22.48–$23.67, opened at $23.59.
- Volume was 116.60K shares, 0.7x its 50-day average of 156.89K.
- Price is -37.6% vs its 50-day average ($36.68) and -31.5% vs its 200-day average ($33.44).
- 52-week range $14.78–$57.14; today's close sits at 19% of that range, 59.9% below the 52-week high.
Oct 7, 2026 — NBTX dips 2.4% to $24.62, a 6-month low
- Closed at $24.62, -2.42% vs the prior close of $25.23. Day range $24.31–$25.12, opened at $24.68.
- Volume was 142.60K shares, 0.9x its 50-day average of 156.57K.
- Price is -33.4% vs its 50-day average ($36.98) and -26.4% vs its 200-day average ($33.44).
- 52-week range $14.78–$57.14; today's close sits at 23% of that range, 56.9% below the 52-week high.
Oct 6, 2026 — NBTX rises 0.5% to $25.23
- Closed at $25.23, +0.52% vs the prior close of $25.10. Day range $24.16–$25.69, opened at $25.69.
- Volume was 156.30K shares, 1.0x its 50-day average of 155.35K.
- Price is -32.2% vs its 50-day average ($37.24) and -24.5% vs its 200-day average ($33.43).
- 52-week range $14.78–$57.14; today's close sits at 25% of that range, 55.8% below the 52-week high.
Oct 5, 2026 — NBTX dips 2.5% to $25.10, a 6-month low, 8 down days in a row
- Closed at $25.10, -2.52% vs the prior close of $25.75. Day range $24.24–$25.97, opened at $25.77.
- Volume was 194.20K shares, 1.3x its 50-day average of 153.54K.
- Price is -33.1% vs its 50-day average ($37.54) and -24.9% vs its 200-day average ($33.41).
- 52-week range $14.78–$57.14; today's close sits at 24% of that range, 56.1% below the 52-week high.
- That makes 8 straight losses.
Oct 2, 2026 — NBTX slides 7.7% to $25.75, a 6-month low, 7 down days in a row
- Closed at $25.75, -7.71% vs the prior close of $27.90. Day range $25.23–$27.42, opened at $27.39.
- Volume was 255.80K shares, 1.7x its 50-day average of 151.49K.
- Price is -31.9% vs its 50-day average ($37.83) and -22.9% vs its 200-day average ($33.39).
- 52-week range $14.78–$57.14; today's close sits at 26% of that range, 54.9% below the 52-week high.
- That makes 7 straight losses.
NBTX latest news & SEC filings
Every SEC filing by or about NBTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade NBTX
- How much it moves: over the last 20 sessions the average daily move was 3.77% (largest 10.5%). That is a volatile stock.
- Liquidity: about 151.00K shares (≈$3.36M) trade per day on average.
- 52-week position: $22.23 vs a range of $14.78–$57.14 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 1, 2026; 6-K Sep 24, 2026; 6-K Sep 24, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NBTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 21.89 | 22.92 | 21.55 | 22.23 | 116.40K |
| Oct 14, 2026 | 21.41 | 21.92 | 21.15 | 21.28 | 80.60K |
| Oct 13, 2026 | 23.11 | 23.11 | 21.22 | 21.49 | 231.30K |
| Oct 12, 2026 | 23.72 | 23.81 | 22.80 | 23.40 | 173.30K |
| Oct 9, 2026 | 23.51 | 24.50 | 23.33 | 23.68 | 93.50K |
| Oct 8, 2026 | 23.59 | 23.67 | 22.48 | 22.90 | 116.60K |
| Oct 7, 2026 | 24.68 | 25.12 | 24.31 | 24.62 | 142.60K |
| Oct 6, 2026 | 25.69 | 25.69 | 24.16 | 25.23 | 156.30K |
| Oct 5, 2026 | 25.77 | 25.97 | 24.24 | 25.10 | 194.20K |
| Oct 2, 2026 | 27.39 | 27.42 | 25.23 | 25.75 | 255.80K |
| Oct 1, 2026 | 29.99 | 30.36 | 27.28 | 27.90 | 192.40K |
| Sep 30, 2026 | 31.73 | 32.90 | 31.16 | 31.16 | 311.40K |
| Sep 29, 2026 | 32.47 | 32.47 | 31.07 | 31.50 | 163.50K |
| Sep 28, 2026 | 32.47 | 34.00 | 31.69 | 32.60 | 49.40K |
| Sep 25, 2026 | 32.57 | 34.06 | 32.25 | 33.31 | 124.60K |
| Sep 24, 2026 | 33.45 | 34.65 | 31.57 | 33.46 | 203.20K |
| Sep 23, 2026 | 36.05 | 36.10 | 34.73 | 35.24 | 127.00K |
| Sep 22, 2026 | 34.65 | 35.80 | 34.07 | 35.15 | 44.00K |
| Sep 21, 2026 | 33.57 | 34.79 | 33.04 | 34.50 | 94.50K |
| Sep 18, 2026 | 34.89 | 35.60 | 33.01 | 33.05 | 149.30K |
About Nanobiotix
Nanobiotix (NBTX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in PARIS, France. State of incorporation: France. Fiscal year ends December 31. SEC CIK 1760854.
NBTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NBTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
NBTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NBTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.